University of Melbourne Collaborates with Thomson Reuters to Advance Biomedical Research

December 15, 2014
Initiative will help students gain a competitive-edge by working with the tools of the trade prior to graduation

PHILADELPHIA, PA, U.S.A - Dec 15, 2014 - The Intellectual Property & Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals and the University of Melbourne, today announced an initiative to increase the impact of the institution’s research in the life sciences with the implementation of CortellisTM  Competitive Intelligence , the life sciences industry’s premier source of timely and accurate information on drug pipeline data, patents, companies and the latest industry news, providing a comprehensive view of the competitive landscape in a selected therapy area.

This initiative will ensure that University of Melbourne’s students have access to the highest quality life science content, including disease briefing and SWOT analysis to better inform their research and provide them with the ability to gain a competitive advantage toward pursuing their future professions with a fluency in Cortellis.  Times Higher Education World University Ranking recently named the University of Melbourne as 13th in the world in Clinical, Pre-Clinical and Health disciplines.

“Our students will benefit greatly from having access to this essential tool and resource,” said Professor Glyn Davis, vice chancellor of the University of Melbourne. “We are pleased to be working with Thomson Reuters to provide our students with a competitive intelligence resource that will bolster their confidence and provide them with a competitive edge in their research, better preparing them for their future careers. As the global research landscape continues to rapidly evolve, it is increasing important for our students to be equipped with the knowledge and experience that will be critical to their success.”

“We are pleased to be working with the University of Melbourne to help grow Australia’s future generation of medical scientists and researchers,” said Jon Brett-Harris, managing director of Life Sciences at Thomson Reuters.

Learn more about Cortellis Competitive Intelligence.

Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. For more information, go to www.thomsonreuters.com.

Jen Breen
+1 215 823 1791
Jennifer.breen@thomsonreuters.com
Molly Malone
+1 215 823 3702
molly.malone@thomsonreuters.com